Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)

Detalles Bibliográficos
Autores principales: Frey, Reiner, Mück, Wolfgang, Kirschbaum, Nina, Krätzschmar, Jörn, Weimann, Gerrit, Wensing, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313325/
http://dx.doi.org/10.1186/1471-2210-9-S1-P15
_version_ 1782227972348968960
author Frey, Reiner
Mück, Wolfgang
Kirschbaum, Nina
Krätzschmar, Jörn
Weimann, Gerrit
Wensing, Georg
author_facet Frey, Reiner
Mück, Wolfgang
Kirschbaum, Nina
Krätzschmar, Jörn
Weimann, Gerrit
Wensing, Georg
author_sort Frey, Reiner
collection PubMed
description
format Online
Article
Text
id pubmed-3313325
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33133252012-03-28 Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521) Frey, Reiner Mück, Wolfgang Kirschbaum, Nina Krätzschmar, Jörn Weimann, Gerrit Wensing, Georg BMC Pharmacol Poster Presentation BioMed Central 2009-08-11 /pmc/articles/PMC3313325/ http://dx.doi.org/10.1186/1471-2210-9-S1-P15 Text en Copyright ©2009 Frey et al; licensee BioMed Central Ltd.
spellingShingle Poster Presentation
Frey, Reiner
Mück, Wolfgang
Kirschbaum, Nina
Krätzschmar, Jörn
Weimann, Gerrit
Wensing, Georg
Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)
title Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)
title_full Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)
title_fullStr Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)
title_full_unstemmed Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)
title_short Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)
title_sort warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (bay 63-2521)
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313325/
http://dx.doi.org/10.1186/1471-2210-9-S1-P15
work_keys_str_mv AT freyreiner warfarinpharmacodynamicsandpharmacokineticsarenotaffectedbythesolubleguanylatecyclasestimulatorriociguatbay632521
AT muckwolfgang warfarinpharmacodynamicsandpharmacokineticsarenotaffectedbythesolubleguanylatecyclasestimulatorriociguatbay632521
AT kirschbaumnina warfarinpharmacodynamicsandpharmacokineticsarenotaffectedbythesolubleguanylatecyclasestimulatorriociguatbay632521
AT kratzschmarjorn warfarinpharmacodynamicsandpharmacokineticsarenotaffectedbythesolubleguanylatecyclasestimulatorriociguatbay632521
AT weimanngerrit warfarinpharmacodynamicsandpharmacokineticsarenotaffectedbythesolubleguanylatecyclasestimulatorriociguatbay632521
AT wensinggeorg warfarinpharmacodynamicsandpharmacokineticsarenotaffectedbythesolubleguanylatecyclasestimulatorriociguatbay632521

Ejemplares similares